← All sarcoma trials
Recruiting now—Ages 18 Years and up

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Sponsor: Universidad Nacional Autonoma de Mexico · NCT06523582 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

Neuroendocrine NeoplasmNeuroendocrine Neoplasm of Gastrointestinal TractNeuroendocrine Neoplasm of LungThymic Neuroendocrine NeoplasmNeuroendocrine Tumor of PancreasGastrointestinal Stromal TumorsMedullary Thyroid CancerParagangliomaPheochromocytomaPrimary HyperparathyroidismPituitary TumorMultiple Endocrine Neoplasia Type 1Multiple Endocrine Neoplasia Type 2Multiple Endocrine Neoplasia Type 4Carney ComplexCarney Stratakis DyadCarney TriadCowden SyndromeDICER1 SyndromeLi-Fraumeni SyndromeLynch SyndromeVon Hippel-Lindau DiseaseFamilial Isolated Pituitary AdenomaX-Linked AcrogigantismNeurofibromatosis 1Tuberous Sclerosis

Where it's running3 sites

3 international sites

  • Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social

    Mexico City, Mexico City, Mexico 06720

    Recruiting now

  • Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

    Mexico City, Mexico City, Mexico 14080

    Recruiting now

  • Red de Apoyo a la Investigación, Coordinación de la Investigación Científica, Universidad Nacional Autónoma de México

    Mexico City, Mexico City, Mexico 14080

    Recruiting now
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

Adult patients with a new or previous clinical diagnosis of any of the following conditions:

* Isolated NENs with sporadic presentation, including bronchopulmonary NENs, gastrointestinal NENs, medullary thyroid carcinoma, pancreatic NENs, paragangliomas, pheochromocytomas, pituitary neuroendocrine tumors, and primary hyperparathyroidism.
* Familial isolated NENs, including familial isolated pituitary adenoma, familial pheochromocytomas and paragangliomas, familial primary hyperparathyroidism, familial gastrointestinal stromal tumors and X-linked acrogigantism.
* Clinical syndromes encompassing NENs, with familial or sporadic presentation, including Carney complex, Carney-Stratakis syndrome, Carney triad, Cowden syndrome, DICER1 syndrome, Li-Fraumeni syndrome, Lynch syndrome, multiple endocrine neoplasia type 1, multiple endocrine neoplasia type 2, multiple endocrine neoplasia type 4, neurofibromatosis type 1, Pacak-Zhuang syndrome, paraganglioma, pheochromocytoma and pituitary adenoma syndrome, tuberous sclerosis complex, Von Hippel Lindau syndrome.

Exclusion criteria:

* Age \<18 years.
* Refusal to give informed consent.

Updated 2024-07-26 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.